PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
35.66%
Net income growth at 75-90% of ORCL's 44.35%. Bill Ackman would call for strategic or operational tweaks to match competitor’s earnings growth.
-4.48%
Negative yoy D&A while ORCL is 9.60%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
-150.58%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
3.40%
SBC growth while ORCL is negative at -10.24%. John Neff would see competitor possibly controlling share issuance more tightly.
5.93%
Less working capital growth vs. ORCL's 172.17%, indicating potentially more efficient day-to-day cash usage. David Dodd would confirm no negative impact on revenue.
-562.34%
Both yoy AR lines negative, with ORCL at -21700.00%. Martin Whitman would suspect an overall sector lean approach or softer demand.
-1143.75%
Negative yoy inventory while ORCL is 245.16%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
300.00%
AP growth well above ORCL's 327.27%. Michael Burry would be concerned about potential late payments or short-term liquidity strain relative to competitor.
47.16%
Lower 'other working capital' growth vs. ORCL's 498.23%. David Dodd would see fewer unexpected short-term demands on cash.
-7.95%
Negative yoy while ORCL is 87.86%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
3.24%
Operating cash flow growth below 50% of ORCL's 65.47%. Michael Burry would see a serious shortfall in day-to-day cash profitability.
-34.69%
Both yoy lines negative, with ORCL at -19.32%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
55.36%
Some acquisitions while ORCL is negative at -47.64%. John Neff sees competitor possibly pausing M&A or divesting while the firm invests in new deals.
33.90%
Some yoy expansion while ORCL is negative at -87.85%. John Neff sees competitor possibly refraining from new investments or liquidating existing ones for immediate cash.
-40.91%
We reduce yoy sales while ORCL is 0.78%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
90.46%
We have some outflow growth while ORCL is negative at -1806.82%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
-19.03%
Both yoy lines negative, with ORCL at -703.02%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
-1496.21%
Both yoy lines negative, with ORCL at -1004.65%. Martin Whitman suspects an environment prompting net new borrowings or weaker paydowns across the niche.
23.46%
Lower share issuance yoy vs. ORCL's 54.88%, implying less dilution. David Dodd would confirm the firm still has enough capital for expansions.
14.40%
Repurchase growth above 1.5x ORCL's 1.28%. David Dodd would see a strong per-share advantage if the share price is reasonably valued.